Gyrus Capital completes strategic equity investment in Neo Medical

Neo Medical SA, a Swiss technology company specializing in spine surgery, has announced the successful completion of a strategic equity investment, including the conversion of existing shareholder loans. With this financing round, Neo has secured an additional equity investment of up to $68 million (CHF 58 million) to accelerate its global growth.

The financing round was led by Gyrus Capital SA, a private equity firm based in Geneva. Including the participation of existing investors, among which founders Vincent Lefauconnier and Jonas Larsson, this landmark round is one of the most significant in the spine industry in the last decade.

The proceeds will be used to increase Neo’s market share in key regions with an immediate focus on expanding the US business, deploying new, complementary, and disruptive products, and enhancing the capabilities of its unique AI driven augmented reality intraoperative data platform, ADVISE.

Lenz & Staehelin advised Gyrus Capital in this equity financing. The team was led by Andreas Rötheli and Federico Trabaldo Togna (both Corporate and M&A) and included Ipek Yüce, David di Rosa, Noé Luisoni, Céline Perone and Victor Sellier (all Corporate and M&A), Floran Ponce and Maximilien de Ridder (both Tax), and Sevan Antreasyan and Anne-Laure Laplace (both IP and Regulatory).